INT175035

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.65
First Reported 2003
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 11
Total Number 12
Disease Relevance 10.10
Pain Relevance 0.19

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell differentiation (Mecom) nucleus (Mecom) intracellular (Mecom)
DNA binding (Mecom)
Anatomy Link Frequency
bone marrow 1
Mecom (Mus musculus)
Pain Link Frequency Relevance Heat
depression 18 87.16 High High
Arthritis 8 72.08 Quite High
cva 6 70.08 Quite High
antidepressant 6 52.48 Quite High
palliative 9 52.08 Quite High
cytokine 4 38.08 Quite Low
Serotonin 2 32.92 Quite Low
Pain 31 19.44 Low Low
Hippocampus 6 5.00 Very Low Very Low Very Low
dexamethasone 5 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Myelodysplastic Syndromes 541 100.00 Very High Very High Very High
Decubitus Ulcers 67 98.60 Very High Very High Very High
Disease Progression 3 90.40 High High
Fatigue 2 89.48 High High
Hypertension 10 88.96 High High
Refractory Anemia 3 88.40 High High
Diarrhoea 2 88.40 High High
Depression 24 87.16 High High
Acute Myeloid Leukemia 22 86.20 High High
Incontinence 38 84.00 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In our conditions, DS lesions increased the choice of the response strategy during early training with no clear difference between mDS and lDS lesions.
Gene_expression (lesions) of mDS
1) Confidence 0.65 Published 2010 Journal Frontiers in Behavioral Neuroscience Section Body Doc Link PMC2831625 Disease Relevance 0 Pain Relevance 0
Effects of lDS and mDS lesions in the strategy choice
Gene_expression (lesions) of mDS
2) Confidence 0.65 Published 2010 Journal Frontiers in Behavioral Neuroscience Section Body Doc Link PMC2831625 Disease Relevance 0 Pain Relevance 0
Thus a method of scoring that was not reliant on the MDS data collection was needed [17].
Gene_expression (collection) of MDS associated with myelodysplastic syndromes
3) Confidence 0.26 Published 2010 Journal BMC Res Notes Section Body Doc Link PMC2913927 Disease Relevance 0.88 Pain Relevance 0
A shortened MDS is used quarterly and following any adverse events.
Gene_expression (used) of MDS associated with myelodysplastic syndromes
4) Confidence 0.26 Published 2010 Journal BMC Res Notes Section Body Doc Link PMC2913927 Disease Relevance 1.04 Pain Relevance 0.05
A statistically significant difference as well as clinically important difference (±0.03) in MDS-HSI between residents without PU and those with PU was observed in most variables.
Gene_expression (residents) of MDS-HSI associated with myelodysplastic syndromes
5) Confidence 0.12 Published 2009 Journal Qual Life Res Section Body Doc Link PMC2804787 Disease Relevance 0.90 Pain Relevance 0
The unadjusted mean ± SD MDS-HSI score of LTC residents without PU was 0.36 ± 0.17 and the MDS-HSI for those with PU was 0.26 ± 0.13.
Gene_expression (residents) of MDS-HSI associated with myelodysplastic syndromes
6) Confidence 0.12 Published 2009 Journal Qual Life Res Section Body Doc Link PMC2804787 Disease Relevance 0.98 Pain Relevance 0
Never being married was significantly associated with higher MDS-HSI scores.
Gene_expression (scores) of MDS-HSI associated with myelodysplastic syndromes
7) Confidence 0.12 Published 2009 Journal Qual Life Res Section Body Doc Link PMC2804787 Disease Relevance 1.48 Pain Relevance 0.14
A statistically significant difference as well as clinically important difference (±0.03) in MDS-HSI between residents without PU and those with PU was observed in most variables.
Gene_expression (those) of MDS-HSI associated with myelodysplastic syndromes
8) Confidence 0.12 Published 2009 Journal Qual Life Res Section Body Doc Link PMC2804787 Disease Relevance 0.91 Pain Relevance 0
Similarly, a 0.10-point or more difference in MDS-HSI between residents without PU and those with PU was also generally observed within levels of demographic variables.
Gene_expression (residents) of MDS-HSI associated with myelodysplastic syndromes
9) Confidence 0.12 Published 2009 Journal Qual Life Res Section Body Doc Link PMC2804787 Disease Relevance 1.02 Pain Relevance 0
Our objectives were to use the MDS-HSI to estimate health status utilities in LTC residents in Ontario, both with and without PUs, and to determine the impact of PU on HRQOL.


Gene_expression (residents) of MDS-HSI associated with decubitus ulcers and myelodysplastic syndromes
10) Confidence 0.12 Published 2009 Journal Qual Life Res Section Body Doc Link PMC2804787 Disease Relevance 0.84 Pain Relevance 0
There is some evidence that the initial introduction of the MDS was associated with improvements in care processes and outcomes, but how universal this is at present is not known.[36,37] Unfortunately, preliminary analyses of the structural factors associated with QI reliability levels provided little insight as to what kinds of facilities are more likely to have adequate reliability.
Gene_expression (introduction) of MDS associated with myelodysplastic syndromes
11) Confidence 0.12 Published 2003 Journal BMC Health Serv Res Section Body Doc Link PMC280691 Disease Relevance 0.16 Pain Relevance 0
In MDS, VEGF is overexpressed by immature myeloid cells in the bone marrow and associated with increased bone marrow vascularity [52].
Gene_expression (overexpressed) of MDS in bone marrow associated with myelodysplastic syndromes
12) Confidence 0.04 Published 2010 Journal Journal of Oncology Section Body Doc Link PMC2875768 Disease Relevance 1.90 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox